Peter T . Silberstein, MD

Professor

Contact

School of Medicine
Department of Medicine
Hematology and Oncology

Peter T . Silberstein, MD

Professor

Department

Medicine

Position

Professor

Books

  • Maresso Karen Colbert, Prevention and Screening Risk Factors, Screening, and Chemoprevention [Book Chapter] 2014

Publications

  • Curēus (Palo Alto, CA)
    Wu Xinxin, Patient and Tumor Factors on Overall Survival in Spindle Cell Melanoma 2024
  • Archives of dermatological research
    Taylor Mitchell A., Comparison of clinicopathologic features and disease-specific survival in vulvar melanoma versus primary cutaneous sites: a retrospective cohort analysis
    316:10, p. 731 2024
  • Gynecologic oncology
    Au Kristine, Demographics in early- versus late-stage endometrial cancer: A National Cancer Database review
    190, p. S308 - S308 2024
  • Dermatologic surgery
    Swedek Michelle, Mohs Micrographic Surgery and Wide Local Excision in Pleomorphic Dermal Sarcoma on a National Scale 2024
  • Journal of clinical gastroenterology
    Hu Robert, Treatment and Survival Disparities in Asian Americans With Hepatocellular Carcinoma 2024
  • The American journal of gastroenterology
    Malik Salman, S1728 Palliative Care Utilization Patterns in Hepatocholangiocarcinoma
    119:10S, p. S1254 - S1254 2024
  • JCO oncology practice
    Patel Jaikin, The role of income level in outcomes and treatment for patients with fibrolamellar hepatocellular carcinoma
    20:10_suppl, p. 127 - 127 2024
  • Curēus (Palo Alto, CA)
    Al Kurnas Mohammed, Impact of Demographics on Early-Stage vs. Stage IV Diagnosis in Amelanotic Melanoma: An Analysis of the National Cancer Database
    16:9, p. e69398 2024
  • Journal of the American Academy of Dermatology
    Swedek Michelle, 52336 The Use of Mohs Micrographic Surgery in Pleomorphic Dermal Sarcoma
    91:3, p. AB337 - AB337 2024
  • Journal of the American Academy of Dermatology
    Tupper Connor J., Increasing Survival for Melanoma with Bony Metastases in the Era of Novel Therapies: A Population-Based Retrospective Analysis 2024
  • Journal of pediatric hematology/oncology
    Billion Taylor, Racial Disparities in Treatment and Outcomes of Pediatric Hepatoblastoma 2024
  • JCO global oncology
    Mishra Anjali, Racial Disparities in Pediatric Patients With Acute Lymphoblastic Leukemia: An NCDB Analysis
    10:Supplement_1, p. 157 - 157 2024
  • JCO global oncology
    Al Kurnas Mohammed, Disparities in Native American Patients With Hepatocellular Carcinoma: An NCDB Analysis
    10:Supplement_1, p. 53 - 53 2024
  • JCO global oncology
    Kennard Jared, Factors Associated With Laser Treatment of Primary Site in 201 Cases of Melanoma
    10:Supplement_1, p. 79 - 80 2024
  • JCO global oncology
    Litz Hunter, Primary Site and Race on Survival Patterns in Esophageal Cancer: A NCDB Study
    10:Supplement_1, p. 151 - 151 2024
  • Fertility and sterility
    Lee Daniel, MALIGNANT STEROID CELL TUMORS: AN ANALYSIS OF DEMOGRAPHICS, DIAGNOSIS AND TREATMENT
    122:1, p. e44 - e44 2024
  • The American journal of surgery
    Cogua Laura M., Intermediate-Sized Follicular Thyroid Cancer Surgical Trends Before and After the 2015 American Thyroid Association Guideline Changes, p. 115830 2024
  • American journal of otolaryngology
    Keirns Darby L., Demographic differences in early vs. late-stage laryngeal squamous cell carcinoma
    45:4, p. 104282 2024
  • British journal of dermatology (1951)
    Wu Xinxin, P058 Healthcare disparity affecting delayed diagnosis in acral lentiginous melanoma
    191:Supplement_1, p. i41 - i41 2024
  • International journal of dermatology
    Choe Sharon I, Comparison of disease-specific survival in penile melanoma versus other cutaneous sites: a SEER national database study 2024
  • Journal of clinical oncology
    Cheema Simardeep, Demographic and socioeconomic factors of enterochromaffin cell carcinoid
    42:16_suppl, p. e16288 - e16288 2024
  • Journal of clinical oncology
    Alban Sierra, Malignant mesenchymoma: A demographic analysis of the National Cancer Database
    42:16_suppl, p. e23556 - e23556 2024
  • Journal of clinical oncology
    Loken Delaney, Mixed liposarcoma: A study of socioeconomic and demographic factors
    42:16_suppl, p. e23527 - e23527 2024
  • Journal of clinical oncology
    Saldhi Prachi, An analysis of treatment trends in sclerosing epithelioid fibrosarcoma
    42:16_suppl, p. e23547 - e23547 2024
  • Journal of clinical oncology
    Nooney Marlaena Nicole, Factors predicting surgical receipt in extracranial rhabdoid tumors
    42:16_suppl, p. e23541 - e23541 2024
  • Journal of clinical oncology
    Diagne Yaye Fatou, Epidemiological trends and socioeconomic factors in malignant peripheral nerve sheath tumors with rhabdomyoblastic differentiation: A National Cancer Database study
    42:16_suppl, p. e23562 - e23562 2024
  • Journal of clinical oncology
    Gill Sukhmani Kaur, Analysis of demographic and socioeconomic factors in mixed type rhabdomyosarcoma using NCDB
    42:16_suppl, p. e23538 - e23538 2024
  • Journal of clinical oncology
    Loken Delaney, Myofibroblastic sarcoma: A study of demographic and socioeconomic factors
    42:16_suppl, p. e23545 - e23545 2024
  • Journal of clinical oncology
    Samuel Maya Mary, Analyzing the effect of treatment modalities on survival in synovial sarcoma
    42:16_suppl, p. 11570 - 11570 2024
  • Journal of clinical oncology
    Chaddha Jasleen Kaur, An NCDB analysis of patient treatment trends in soft tissue angiosarcoma
    42:16_suppl, p. e23563 - e23563 2024
  • Journal of clinical oncology
    Gill Sukhmani Kaur, Spindle cell rhabdomyosarcoma: A study of demographics and socioeconomic factors using NCDB
    42:16_suppl, p. e23539 - e23539 2024
  • Journal of clinical oncology
    Bitar Gabriel Anthony, Pancreatoblastoma: A study of demographic and socioeconomic factors
    42:16_suppl, p. e16345 - e16345 2024
  • Journal of clinical oncology
    Al Kurnas Mohammed, Influence on surgical approach in hepatocholangiocarcinoma: A demographic and socioeconomic analysis
    42:16_suppl, p. e16280 - e16280 2024
  • Journal of clinical oncology
    Tade Yanick, The demographics of Sertoli cell carcinoma: A National Cancer Database analysis
    42:16_suppl, p. e17012 - e17012 2024
  • Journal of clinical oncology
    Peterson Michael, Extra-adrenal paraganglioma demographic data: A NCDB study
    42:16_suppl, p. e16293 - e16293 2024
  • Journal of clinical oncology
    Dentinger Lauren, Factors associated with the receipt of palliative care in Native American patients with hepatocellular carcinoma: A retrospective analysis
    42:16_suppl, p. e16202 - e16202 2024
  • Journal of clinical oncology
    Murugan Vikram, Factors associated with surgical intervention in Native American patients with hepatocellular carcinoma
    42:16_suppl, p. e16279 - e16279 2024
  • Journal of clinical oncology
    Choe Sharon, Malignant blue nevus: Epidemiology, socioeconomic factors, and disease presentation
    42:16_suppl, p. e21565 - e21565 2024
  • Journal of clinical oncology
    Cogua Laura, Time to treatment and follicular thyroid cancer survival: A SEER database analysis
    42:16_suppl, p. e13794 - e13794 2024
  • Journal of clinical oncology
    Choe Sharon, Epidemiology and clinical management of primary penile melanoma: A review of the National Cancer Database
    42:16_suppl, p. e21570 - e21570 2024
  • Journal of clinical oncology
    Demangone Michael, Incidence and demographics of bile duct cystadenocarcinoma from the National Cancer Database
    42:16_suppl, p. e16231 - e16231 2024
  • Journal of clinical oncology
    Thompson Alexander, Socioeconomic and demographic factors in multifocal superficial basal cell carcinoma: An NCDB analysis
    42:16_suppl, p. e21576 - e21576 2024
  • Journal of clinical oncology
    Diagne Yaye Fatou, Demographic and socioeconomic analysis of patients with glucagonoma: Insights from the National Cancer Database
    42:16_suppl, p. e16319 - e16319 2024
  • Journal of clinical oncology
    Devireddy Shalika, An NCDB analysis of the predictive factors associated with the receival of tumor resection in mucinous cystadenoma of the pancreas
    42:16_suppl, p. e16356 - e16356 2024
  • Journal of clinical oncology
    Braun John Paul, Impact of treatment setting on survival outcomes in undifferentiated pancreatic carcinoma: An analysis of the National Cancer Database
    42:16_suppl, p. e16333 - e16333 2024
  • Journal of clinical oncology
    Becken Aidan John, Longitudinal survival and complete tumor resection rates in Native American patients with hepatocellular carcinoma treated at academic institutions
    42:16_suppl, p. e16281 - e16281 2024
  • Journal of clinical oncology
    Han Emily, Fetal adenocarcinoma: An NCDB analysis of socioeconomic and demographic factors
    42:16_suppl, p. e20076 - e20076 2024
  • Journal of clinical oncology
    Dudic Ahmed, High-grade surface osteosarcoma: A National Cancer Database study of demographic characteristics
    42:16_suppl, p. e23508 - e23508 2024
  • Journal of clinical oncology
    Chin Kat, The epidemiology and demographic statistics of serrated adenocarcinoma
    42:16_suppl, p. e15645 - e15645 2024
  • Journal of clinical oncology
    Nowlen Frances, Hodgkin’s lymphoma, lymphocyte-depleted, reticular: An NCDB analysis of demographic and socioeconomic factors of diagnosed patients
    42:16_suppl, p. e19033 - e19033 2024
  • Journal of clinical oncology
    Nowlen Frances, Small cell osteosarcoma: An NCDB analysis of demographic and socioeconomic factors of diagnosed patients
    42:16_suppl, p. e23504 - e23504 2024
  • Journal of clinical oncology
    Alban Sierra, An NCDB demographic and socioeconomic analysis of mixed acinar ductal carcinoma
    42:16_suppl, p. e17097 - e17097 2024
  • Journal of clinical oncology
    Khatib Rawaan, Perivascular epithelioid cell tumors: A study of demographic and socioeconomic factors
    42:16_suppl, p. e17594 - e17594 2024
  • Journal of clinical oncology
    Becker Ashley, Racial disparities in pediatric patients with acute myeloid leukemia
    42:16_suppl, p. 10031 - 10031 2024
  • Journal of clinical oncology
    Ramos Brianna Eillen, Demographic factors of malignant endometrioid adenofibroma: An NCDB study
    42:16_suppl, p. e17592 - e17592 2024
  • Journal of clinical oncology
    Mathews Maya, Demographic factors of prognosis in pediatric neuroblastoma
    42:16_suppl, p. 10041 - 10041 2024
  • Journal of clinical oncology
    Cronen Austin, Analysis of demographic and socioeconomic factors in adamantinoma using data from the National Cancer Database (NCDB)
    42:16_suppl, p. e23501 - e23501 2024
  • Journal of clinical oncology
    Johanis Amit, Adenocarcinoma in multiple adenomatous polyps: An analysis of demographic and socioeconomic factors
    42:16_suppl, p. e15619 - e15619 2024
  • Journal of clinical oncology
    Ramos Brianna Eillen, Pulmonary blastoma: An NCDB analysis of demographic and socioeconomic factors
    42:16_suppl, p. e20069 - e20069 2024
  • Journal of clinical oncology
    Abi Karam Karam Rabih, Demographic insights in systemic EBV-positive T-cell lymphoproliferative disease of childhood: A comprehensive NCDB analysis
    42:16_suppl, p. e19077 - e19077 2024
  • Journal of clinical oncology
    Puvvadi Suraj, Demographics and socioeconomic factors of adenocarcinoma with apocrine metaplasia
    42:16_suppl, p. e12588 - e12588 2024
  • Journal of clinical oncology
    Bitar Gabriel Anthony, Analysis of demographic and socioeconomic factors in biphasic synovial sarcoma using data from the National Cancer Database
    42:16_suppl, p. e23524 - e23524 2024
  • Journal of clinical oncology
    Peterson Michael, Juxtacortical chondrosarcoma: An NCDB analysis of demographics and socioeconomic factors
    42:16_suppl, p. e23505 - e23505 2024
  • Journal of clinical oncology
    Cronen Austin, Malignant chondroblastoma: NCDB analysis of demographic and socioeconomic factors
    42:16_suppl, p. e23500 - e23500 2024
  • Journal of clinical oncology
    Au Kristine, Demographic factors influencing hysterectomy approaches (with vs. without removal of tubes and/or ovaries): An NCDB review
    42:16_suppl, p. e17578 - e17578 2024
  • Journal of clinical oncology
    Anderson Quinton, Pagetic osteosarcoma: An analysis of the National Cancer Database
    42:16_suppl, p. e23503 - e23503 2024
  • Journal of clinical oncology
    Chin Kat, Dedifferentiated chordoma: Socioeconomic factors and treatment outcomes
    42:16_suppl, p. e23507 - e23507 2024
  • Journal of clinical oncology
    Khatib Rawaan, Periosteal osteosarcoma: A study of demographic and socioeconomic factors
    42:16_suppl, p. e23506 - e23506 2024
  • Obstetrics and gynecology (New York. 1953)
    Mishra Anjali, Disparities in Overall Survival Within AANHPI Subpopulations With Cervical Cancer [ID 2683427]
    143:5S, p. 12 - 13S 2024
  • Cancer research (Chicago, Ill.)
    Kurnas Mohammed Al, Abstract 4863: A retrospective study characterizing 1714 cases of epithelioid cell melanoma
    84:6_Supplement, p. 4863 - 4863 2024
  • Cancer research (Chicago, Ill.)
    Brandt Zachary G., Abstract 3566: Mohs surgery trends in 104 cases of pediatric melanoma
    84:6_Supplement, p. 3566 - 3566 2024
  • Curēus (Palo Alto, CA)
    Tupper Connor J, Extent of Surgery and Survival of Osteosarcoma: A Retrospective Population-Based Study
    16:3, p. e56030 2024
  • Journal of the American Academy of Dermatology
    Tupper Connor J, Improved Survival Outcomes for Melanoma of Unknown Primary in the Era of Novel Therapies: A Population-Based Retrospective Analysis 2024
  • Pediatric hematology oncology journal
    Mishra Anjali, Racial disparities in pediatric patients with acute lymphoblastic leukemia: An National Cancer Database analysis
    9:1, p. 40 - 41 2024
  • Journal of clinical oncology
    Lee Aron, Patient factors and survival outcomes of pancreatic signet cell carcinoma: A comprehensive review and analysis
    42:3_suppl, p. 608 - 608 2024
  • Journal of clinical oncology
    Lanoue Connor, Patterns of surgery and adjuvant therapy in pancreatic carcinoid tumor: An NCDB analysis
    42:3_suppl, p. 631 - 631 2024
  • Journal of clinical oncology
    Czaplicki Alec, Disparities in surgical outcomes and survival based on insurance status among patients with fibrolamellar hepatocellular carcinoma: A national perspective
    42:3_suppl, p. 440 - 440 2024
  • Journal of clinical oncology
    Mishra Anjali, Disparities in survival in Asian American, Native Hawaiian, and Pacific Islander patients with gastric adenocarcinoma: An NCDB analysis
    42:3_suppl, p. 253 - 253 2024
  • Journal of clinical oncology
    Nielsen Eric G., Income and its impact on adenomatous neoplasms outcomes: An analysis of the National Cancer Database
    42:3_suppl, p. 723 - 723 2024
  • Journal of clinical oncology
    Chaddha Jasleen Kaur, Factors associated with the receipt of surgery in acinar cell carcinoma of the pancreas
    42:3_suppl, p. 668 - 668 2024
  • Journal of clinical oncology
    Bine Christopher Reese, Evaluating local tumor destruction and wedge or segmental resection in the treatment of fibrolamellar hepatocellular carcinoma: An NCDB analysis
    42:3_suppl, p. 512 - 512 2024
  • European journal of medical research
    Braaten Marco, Survival and treatment in older patients with ewing sarcoma: an analysis of the national cancer database
    29:1, p. 29 - 2024
  • Journal of clinical oncology
    Thota R., Clinicopathologic features and survival outcomes of primary signet ring cell carcinoma of colon: Retrospective analysis of VACCR database
    29:15_suppl, p. e14097 - e14097 2011
  • Journal of clinical oncology
    Kaminski A. M., Low rates of cancer-directed surgery for pancreatic adenocarcinoma despite favorable patient demographics and tumor stage
    29:15_suppl, p. e14600 - e14600 2011
  • Journal of clinical oncology
    Krishnamurthy J., Hodgkin lymphoma of the elderly veterans: Veterans Affairs Cancer Registry analysis
    29:15_suppl, p. 9138 - 9138 2011
  • Journal of clinical oncology
    Abu Hazeem M., The impact of lymph node ratio (LNR) on survival in patients with stage IV colon cancer: A Veteran’s Affairs Central Cancer Registry analysis
    29:15_suppl, p. e14092 - e14092 2011
  • Journal of clinical oncology
    Tashi T., Surgical resection in early limited-stage small cell lung cancer: Time to rethink? A retrospective analysis of the VA Central Cancer Registry
    29:15_suppl, p. 7021 - 7021 2011
  • Journal of clinical oncology
    Subbiah S., Malignant pleural mesothelioma (MPM): Retrospective analysis of clinicopathologic and survival data of the Veterans Affairs Cancer Registry (VACCR)
    29:15_suppl, p. e18002 - e18002 2011
  • Journal of clinical oncology
    Wilkes A., Primary non-Hodgkin lymphoma of the colon: A Veterans Affairs Central Cancer Registry analysis
    29:15_suppl, p. e18525 - e18525 2011
  • Journal of clinical oncology
    Didwaniya N., Survival outcomes in metastatic renal carcinoma based on histological subtypes: SEER database analysis
    29:7_suppl, p. 381 - 381 2011
  • Journal of clinical oncology
    Didwaniya N., Racial disparities in colon cancer: Retrospective analysis of VACCR database
    29:4_suppl, p. 528 - 528 2011
  • Journal of clinical oncology
    Thota R., Primary signet ring cell carcinoma of colon: Retrospective analysis of VACCR database
    29:4_suppl, p. 58 - 58 2011
  • Journal of clinical oncology
    Didwaniya N., Survival outcomes based on race in gastric carcinoma: A SEER database analysis
    29:4_suppl, p. 5 - 5 2011
  • Journal of clinical oncology
    Thota R., Prognostic significance of positive lymph node ratio in resected esophageal cancer
    29:4_suppl, p. 100 - 100 2011
  • Journal of clinical oncology
    Tashi T., Primary non-Hodgkin lymphoma of the colon among patients in the Veterans Affairs Health System
    29:4_suppl, p. 554 - 554 2011
  • Journal of clinical oncology
    Tashi T., Survival outcome in resectable esophageal cancer: Single-center experience
    28:15_suppl, p. e14665 - e14665 2010
  • Journal of clinical oncology
    Kanuri S., Clinicopathologic factors and outcomes associated with lymph node retrieval in resectable colon cancer
    28:15_suppl, p. 3608 - 3608 2010
  • European journal of cancer supplements
    Rearden T., 1141 POSTER Evaluation of extended dosing intervals versus weekly dosing of darbepoetin alfa (DA): A phase 2 study in cancer patients (pts) with chemotherapy-induced anemia (CIA)
    5:4, p. 154 - 154 2007

Presentations

  • Angiosarcoma: An Analysis of the National Cancer Database (NCDB) Authors: Gia Thinh D. Truong, Zachary A. Creech, Peter T. Silberstein AVAHO (American Veterans Hematology Oncology) Denver, Colorado, 9/24/2021 2021
  • Julia Griffin, Timothy Malouff, Peter Silberstein. Palliative Care Disparities in Stage IV Melanoma Patients: An Analysis of the National Cancer Database AVAHO (American Veterans Hematology Oncology) Denver, Colorado, 9/24/2021 2021
  • Greg Cichon, Mary Beth Dahl, Peter Silberstein. Patterns of Palliative Care in Stage IV Esophageal Cancer.AVAHO (American Veterans Hematology Oncology) Denver, Colorado, 9/24/2021 2021
  • Mary Beth Dahl, Greg Cichon, Peter Silberstein. Patterns of Palliative Care Utilization in Patients with Glioblastoma: An Analysis of the National Cancer Database.AVAHO (American Veterans Hematology Oncology) Denver, Colorado, 9/24/2021 2021
  • Survival of Patients with Stage IV Melanoma of Unknown Primary in the Era of Immunotherapy: A SEER Database Study. Connor Tupper, BA and Peter Silberstein, MD. ASCO National Meeting, June 2021 2021
  • Retrospective Analysis of Adamantinoma :Epidemiological Factors from the National Cancer Database (NCDB/NCD). Kevin M. McMahon, Michael J. Shonnard, and Thomas T. Nilles-Melchert ASCO National Meeting, June 2021 2021
  • Patterns of use of palliative interventions in elderly patients with acute myelogenous leukemia (AML): A National Cancer Database (NCDB) Study. Hussain Rangoonwala, Mary Dahl, Sai Gundepalli, Jonathan Gootee, Peter Silberstein, Lyle Fettig. American Society of Clinical Oncology Medical Student and Resident Abstract Forum; 2021. 2021
  • The effect of treatment facility and race on survival for signet ring cell carcinoma of the esophagus: an analysis of the National Cancer Database. Willman C, Gootee J, Silberstein P, Aurit S. AVAHO, online due to COVID. 2020
  • The importance of adjuvant treatment and primary anatomical site in head and neck basaloid squamous cell carcinoma survival: an analysis of the National Cancer Database. Patel M, Gootee J, Aurit S, Silberstein P. AVAHO, online due to COVID. 2020
  • The importance of adjuvant treatment and primary anatomical site in head and neck basaloid squamous cell carcinoma survival: an analysis of the National Cancer Database. Gootee J, Patel M, Aurit S, Silberstein P. Global Health Conference Midwest, Omaha, Nebraska. 2020
  • Epidemiology and Survival Outcomes in Elderly Acute Myeloid Leukemia Patients: An NCDB study. Rangoonwala, H., Gootee, J., Silberstein, P.T. American Society of Hematology Annual Meeting, Orlando, FL. (Poster Presentation) 2019
  • Trends in Autologous Stem Cell Transplant in the Era of Novel Multiple Myeloma Agents. Vardell, V.A., Ermann, D.A., Gbadamosi-Akindele, M., Silberstein, P.T., Tantravahi, S. American Society of Hematology Annual Meeting, Orlando, FL. (Oral Presentation) 2019
  • Angioimmunoblastic T-Cell Lymphoma. Ermann, D.A., Vardell, V.A., & Silberstein, P.T. merican Society of Hematology Annual Meeting, San Diego, CA. (Poster Presentation) 2019
  • Angioimmunoblastic T-Cell Lymphoma. Ermann, D.A., Vardell, V.A., & Silberstein, P.T. American Society of Hematology Annual Meeting, San Diego, CA. (Poster Presentation) 2019
  • Sickle Cell Disease Is A Prognostic Indicator Of Increased In-Hospital Mortality In Heart Failure Admissions: Results Of A National Inpatient Sample Database Study. Maryam Gbadamosi-Akindele, Dinesh Reddy Apala, Janani Baskaran, Sara Albagoush, Aravdeep Jhand, Daniel Ermann, Sarah Aurit, Hussain Rangoonwala, Margaret Butler, Peter Silberstein. AHA Scientific Sessions, Philadelphia, PA. 2019
  • The effect of treatment facility on survival for signet ring cell carcinoma of the esophagus: an analysis of the National Cancer Database. Omaha, NE. (Poster Presentation) 2019
  • An Uncommon Complication of Chronic Myelomonocytic Leukemia: Acute Monocytic Transformation and Leukostasis. Rangoonwala, H.I., Ermann, D., Gbadamosi-Akindele, M., Silberstein, P. T. Association of Veteran Affairs Hematology/Oncology Annual Meeting, Minneapolis, MN. (Poster Presentation) 2019
  • Demographic Factors of Patients with Oligodendroglioma: A NCDB Analysis. Ahmed, H., Silberstein, P.T. Association of Veteran Affairs Hematology/Oncology Annual Meeting, Minneapolis, MN. (Poster Presentation) 2019
  • Effect of Primary Site and Other Prognostic Factors on Survival in Myxoid Liposarcoma. Dickan, A., Gootee, J., Aurit, S., Curtin, C., Silberstein, P.T. Association of Veteran Affairs Hematology/Oncology Annual Meeting, Minneapolis, MN. (Poster Presentation) 2019
  • Primary Anatomical Site as a Prognostic Determinant for Pleomorphic Liposarcoma. Lee, H. G., Aurit, S., Gootee, J., Silberstein, P.T. Association of Veteran Affairs Hematology/Oncology Annual Meeting, Minneapolis, MN.(Poster Presentation). 2019
  • Primary Cardiac Sarcoma: An Analysis of the National Cancer Database. Vardell, V.A., Ermann, D.A., & Silberstein, P.T. Association of Veteran Affairs Hematology/Oncology Annual Meeting, Minneapolis, MN. (Poster Presentation) 2019
  • Prognostic significance of primary tumor location in breast cancer: An Analysis of the National Cancer Database (NCDB). Abushalha, K., Albagoush, S., Aurit, S., Silberstein, P.T., Abulaimoun, S. Association of Veteran Affairs Hematology/Oncology Annual Meeting, Minneapolis, MN. (Poster Presentation) 2019
  • The Importance of Surgical Margins in Dedifferentiated Liposarcoma. Nguyen, K., Gootee, J., Aurit, S., Curtin, C., Silberstein, P.T. Association of Veteran Affairs Hematology/Oncology Annual Meeting, Minneapolis, MN. (Poster Presentation) 2019
  • Angioimmunoblastic T-Cell Lymphoma" Ermann, D.A., Vardell, V.A., & Silberstein, P.T. Association of Veteran Affairs Hematology/Oncology Annual Meeting, Minneapolis, MN. (Poster Presentation) 2019
  • Effect of Primary Site and Other Prognostic Factors on Survival in Myxoid Liposarcoma. Dickan, A., Gootee, J., Aurit, S., Curtin, C., Silberstein, P.T. American Society of Clinical Oncology Annual meeting, Chicago, IL. (Poster Presentation) 2019
  • Primary Cardiac Lymphoma: An Analysis of the National Cancer Database. Vardell, V.A., Ermann, D.A., Silberstein, P.T. Hem/Onc Research Conference, University of Nebraska Medical Center, Omaha, NE. (Poster Presentation) 2019
  • Hospital Volume as an Independent Predictor of Lymph Node Yield in Patients Undergoing Neck Dissection for Oral Squamous Cell Carcinoma: An Analysis of the National Cancer Database. Victoria Vardell Noble, Daniel Arthur Ermann MD, Sarah Aurit, Peter Silberstein MD, Aru Panwar MD. American Head and Neck Society, Austin, TX. (Poster Presentation) 2019
  • Primary Site and Other Prognostic Variables Effects on Survival in Pediatric Synovial Sarcoma. Jonathan Gootee, Isabel Gonzaga, Christina Curtin, Peter Silberstein MD. Global Health Conference Midwest, Omaha, NE. (Poster Presentation) 2019
  • Surgical Margins: An Important Prognostic Factor in Leiomyosarcoma Survival-Natasha Sioda, Jonathan Gootee, Sarah Aurit, Christina Curtin, Peter Silberstein MD. NAFP Annual Meeting and Scientific Assembly, Omaha, NE. (Poster Presentation) 2019
  • Epidemiology and Survivorship of Chondrosarcoma in the United States: An analysis of the National Cancer Database (NCDB) - Kang, B.Y., Gonzaga, I., Gootee, J., Randhawa, S., Olsen, B., Aeilts, L., Aurit, S.J., Curtin, C., and Silberstein, P.T. Midwest Student Biomedical Research Forum, Omaha, NE. (Poster Presentation) 2019
  • The Importance of Surgical Margins in Dedifferentiated Liposarcoma Treatment- Kevin Nguyen, Jonathan Gootee, Sarah Aurit, Christina Curtin, Peter Silberstein MD. Global Health Conference Midwest, Omaha, NE. (Poster Presentation) 2019
  • Refusal of Radiotherapy in High Grade Soft Tissue Sarcoma of the Extremities --M. Isabel Gonzaga, Mary Dick, Sarah Aurit, Peter Silberstein MD. Midwest Student Biomedical Research Forum, Omaha, NE. (Poster Presentation) 2019
  • Insurance status and hepatocellular carcinoma: A NCDB analysis. Ahmed, Hibah, Peter T. Silberstein MD. Gastrointestinal Cancers Symposium, San Francisco, CA. (Poster Presentation) 2019
  • Academic Centers Are Associated with Improved Survival Outcomes in High Risk Diffuse Large B-cell Lymphoma Patients Daniel A. Ermann MD, Victoria Vardell Noble, Ayatka Kallam MBBS, Peter Silberstein MD, James O. Armitage MD. American Society of Hematology Annual meeting, San Diego, CA, December 1-4, 2018. (Poster Presentation) 2018
  • Primary Thyroid Lymphoma: An Analysis of the National Cancer Database Victoria Vardell Noble, Daniel Arthur Ermann MD, Peter Silberstein MD. American Society of Hematology Annual meeting, San Diego, CA, December 1-4, 2018. (Poster Presentation) 2018
  • Epidemiology and Survivorship of Anaplastic Large Cell Lymphoma Janani Baskaran MD, Jonathan Gootee, Victoria Vardell Noble, Peter Silberstein, MD. American Society of Hematology Annual meeting, San Diego, CA, December 1-4, 2018. (Poster Presentation) 2018
  • Primary Thyroid Lymphoma: An Analysis of the National Cancer Database Victoria Vardell Noble, Daniel Arthur Ermann MD, Peter Silberstein MD. ACP NE Annual Meeting, Omaha, NE October 28, 2018. 2018
  • Treatment Facility: An Important Prognostic Factor for Dedifferentiated Liposarcoma Survival. Jonathan Gootee, Christina Curtin, Sarah Aurit, Saboor Randhawa, Bianca Kang, Peter Silberstein, MD. ACP NE Annual Meeting, Omaha, NE, October 28, 2018. 2018
  • Hemophagocytic Lymphohistiocytosis masquerading as Sepsis- Ammara Khan, Mukund Kumar, Janani Baskaran, Peter Silberstein. ACP Nebraska Annual Meeting, Omaha, NE. 2018
  • Primary Anatomical Site and Other Prognostic Variables for Dedifferentiated Liposarcoma. Jonathan Gootee, Saboor Randhawa, MD, Bianca Kang, BS, Isabel Gonzaga, BS, Christina Curtin, Peter Silberstein, MD. AVAHO Annual Meeting, Chicago, IL, September 28-30, 2018 (poster presentation). 2018
  • Epidemiology and Survivorship of Chondrosarcoma in the United States: An analysis of the National Cancer Database (NCDB). Bianca Kang, BS, Isabel Gonzaga, BS, Jonathan Gootee, Saboor Randhawa, MD, Braden Olsen, BS, Luke Aeilts, BS, Christina Curtin, MS, Peter Silberstein, MD. AVAHO Annual Meeting, Chicago, IL, September 28-30, 2018 (poster presentation). 2018
  • Prognostic Factors, Treatment and Survival in Primary Cardiac Sarcoma. Isabel Gonzaga, BS, Jonathan Gootee, Bianca Kang, BS, Christina Curtin, MS, Peter Silberstein, MD. AVAHO Annual Meeting, Chicago, IL, September 28-30, 2018 (poster presentation). 2018
  • Hospital Volume as an Independent Predictor of Lymph Node Yield in Patients Undergoing Neck Dissection for Oral Squamous Cell Carcinoma: An Analysis of the National Cancer Database. Victoria Vardell Noble, Daniel Arthur Ermann MD, Sarah Aurit, Peter Silberstein MD, Aru Panwar MD. AVAHO Annual Meeting, Chicago, IL. (poster presentation) 2018
  • Demoraphics and Survival of Patients Diagnosed with Myxoid Leiomosarcoma: A National Cancer Database (NCDB) Review. Jonathan Gootee, Isabel Gonzaga, Elida Voth, MD, Christina Curtin, Peter Silberstein, MD, Leah Grant, MD. AASCO Annual Meeting - Cancer Interest Group, Chicago, IL, June 4, 2018 (poster presentation). 2018
  • The Epidemiology and Survivorship of Clear Cell Sarcoma: A National Cancer Database (NCDB) Review. Jonathan Gootee, Isabel Gonzaga, Elida Voth, MD, Christina Curtin, Peter Silberstein, MD, Leah Grant, MD. AASCO Annual Meeting - Cancer Interest Group, Chicago, IL, June 4, 2018 (poster presentation). 2018
  • Chemotherapy use in the elderly for stage IV pancreatic cancer: An NCDB analysis. - Aabra Ahmed, B.S., Jenna Sitenga, B.S., Gregory Aird, B.A., Ryan W. Walters, PhD, Peter T. Silberstein, MD - Gastrointestinal Cancers Symposium, San Francisco, CA, January 2018. Poster Presentation. 2018
  • The Association between Cancer Program and Stage IV Breast Cancer Survival: An NCDB Analysis. Author: Margaret Siu, Ryan W. Walters, PhD, Aabra Ahmed, Yu-Soon Park, and Peter Silberstein, MD. Fontainebleau Miami Beach, Florida, March 9 - 12, 2017 2017
  • Survival Differences Following Mastectomy or Lumpectomy with or without adjuvant radiotherapy in Stage III Breast Cancer: An NCDB analysis. Yu-Soon A. Park BS, Ryan W. Walters PhD, Aabra Ahmed BS, Karen Dionesotes BS, Margaret Siu BS, Peter Silberstein, MD 34th Annual Breast Cancer Conference Fontainebleau Miami Beach Hotel, Miami Beach, Florida March 9-12, 2017 2017
  • Multi-Agent and Single-Agent Chemotherapy in Stage IV Pancreatic Cancer: An ACDB Analysis Aabra Ahmed, Ryan W. Walters, Timothy Dean Malouff, Lakshmi Manogna Chintalacheruvu, Peter T. Silberstein. ASCO 2017 Gastrointestinal Cancers Symposium San Francisco, CA January 20, 2017 2017
  • Adjuvant Therapy in Stage II Pancreatic Cancer: An NCDB Analysis Aabra Ahmed, Ryan W. Walters, Timothy Dean Malouff, Mridula Krishnan, Javaneh Jabbari, Peter T. Silberstein. ASCO 2017 Gastrointestinal Cancers Symposium San Francisco, CA January 20, 2017 2017
  • Olson, E., Wolfe, K., Droessler, J., Gries, J., Silberstein, Peter-Epidemiology of Stage IV Thyroid Cancer Patients: A Review of the National Cancer Database 2000-2012. AVAHO Annual Meeting, October 2015, Washington, D.C. 2015
  • Wolfe, K., Droessler, J., Olson, E., Gries, J., Goyal, G., Silberstein, Peter-Patterns in the Use of Neoadjuvant and Adjuvant Therapy in Stage II and III Rectal Cancer and Associated Survival. AVAHO Annual Meeting, October 2015, Washington, D.C. 2015
  • Droessler, J.D., Wolfe, K.M., Olson, E., Silberstein, Peter-Stage IV Rectal Cancer Trends By Year-A Review of the National Cancer Database 1998-2009. AVAHO Annual Meeting, October 2015, Washington, D.C. 2015
  • Impact of Demographic and Health System Variables on Survival in Early Stage (Stage 1 and II) Non Small Cell Lung Carcinoma:A National Cancer Database Analysis-Goyal, G., Monirul-Islam, K.M., Silberstein, P.T.-AVAHO Annual Meeting, October 2015, Washington, D.C. Oral Presentation 2015
  • Immunotherapy in Stage III Melanoma: A Population-Based Analysis of Demographic and Health System Factors Using National Cancer Database (NCDB)-Miyashiro, D., Goyal, G., Silberstein, Peter. Canadian Melanoma Conference, May 2015, Whistler, BC. Oral Presentation 2015
  • Trend Analysis of the Treatment of Stage III Rectal Carcinoma Patients Using National Cancer Database (NCDB)-Upadhyay, Smirty, Dahal, Sumit, Khanal, Nabin, Bhatt, Vijaya Raj, Silberstein, Peter, Mukherjee, Sandeep. Digestive Disease Week, May 2015. Poster Presentation 2015
  • Immunotherapy in Stage III Melanoma: A Population-Based Analysis of Demographic and Health System Factors Using National Cancer Database (NCDB)-Miyashiro, D., Goyal, G., Silberstein, Peter. ACP National Meeting, Feb 2015, Boston, MA. Oral Presentation-Award for Top 10 Medical Students in the Country 2015
  • Epidemiology of Stage IV Breast Cancer Patients: A Review of the National Cancer Database 2000-2011- Gries, Jessica, Do, Van T.H., Silberstein, Peter. San Antonio Breast Cancer Symposium, Dec 2014. Poster Presentation-Selected for Oral Discussion 2014
  • Cutaneous Invasive In-Situ Melanoma in Older Patients: A Retrospective Trend Analysis of National Cancer Data Base(NCDB)-Dahal, S., Bhatt, VR., Shrestha, R., Ganti, AK., Silberstein, Peter- ACP Nebraska Chapter, Oct 2014, Omaha, NE. Poster Presentation 2014
  • Chemotherapy Use in the Treatment of Glioblastoma Multiforme: Comparing Patient Characteristics Using the National Cancer Data Base (NCDB)- Inserra, Chris, Silberstein, P- ASCO Quality Care Symposium, Oct 2014, Boston, MA. Poster Presentation 2014
  • An Atypical Cause of Extreme Leukocytosis and Cytopenia in a 49 year old Woman-Hausmann, H., Bhatt, VR., Silberstein, P.T., Ganti, AK-ACP Nebraska Chapter Abstract Competition; Oct 2014, Omaha, NE. Poster Presentation 2014
  • Demographic Disparities Related to First Course Treatment for Patients with Stage II Prostate Cancer at A Veterans Affairs (VA) Hospital and ACOS Accredited Hospitals in the US-Kim, DM, Schaefer, J, Hoffmann, JM, Silberstein, P-AVAHO, September 2014, Portland, OR. Poster Presentation 2014
  • Systemic Therapy Use in Stage IV Pancreatic Cancer: Comparison Between VA-Nebraska Western Iowa and National Database Using National Cancer Database (NCDB)-Khanal, N, Upadhyay, S, Silberstein, P.-AVAHO, September 2014, Portland, OR. Poster Presentation 2014
  • Use of Adjuvant Chemotherapy in Stage III Colon Cancer:Analysis of National and VA Nebraska-Western Iowa Health Care System Data Using National Caner Datatbase(NCDB)-Upadhyay, S, Dahal, S, Silberstein, P.-AVAHO, September 2014, Portland, OR. Poster Presentation 2014
  • Demographic and Other Characteristics of Nodal Non-Hodgkins Lymphoma Managed in Academic Versus Non-Academic Centers-Bhatt, VR., Dahal, S., Bociek, GR., Silberstein, Peter., Armitage, JO-Pan Pacific Lymphoma Conference, July 2014, Kohala Coast, HI. Poster Presentation 2014
  • Chemotherapy Use in Stage III Colon Cancer: A National Cancer Data Base (NCDB) Analysis-Dahal, Sumit, Bhatt, Vijaya Raj, Silberstein, Peter-J Clin Oncol 32;5s, 2014 (suppl: abstr 3576). ASCO Annual Meeting, May 2014, Chicago, IL. Poster Presentation 2014
  • Clincopathologic Characteristics and Management of Trends of Cutaneous Melanoma Among Older Patients: A National Cancer Data Base(NCDB) Analysis-Raj Bhait, Vijaya, Shrestha, Rajesh, Krishnamurthy, Jairam, Mosalpuria, Kailash, Loberiza, Fausto R., Kishor Ganti, Apar, Silberstein, Peter-J Clin Oncol 32:5s, 2014 (suppl; abstr 9059). ASCO Annual Meeting, May 2014, Chicago, IL. Poster Presentation 2014
  • Discrepencies in Treatment of Osteosarcoma According to Insurance Coverage: A Review of the National Cancer Data Base-Longo, Mimi, Silberstein, Peter-J Clin Oncol 32:5s, 2014 (suppl; abstr 10072). ASCO Annual Meeting, May 2014, Chicago, IL. Poster Presentation 2014
  • Treatment Modalities Used for Stage III/IV Melanoma Therapy in Veterans Affairs Hospitals, AVAHO (Association of VA Hematology/Oncology)- Al Dhaybi, O, Bha, VR, Silberstein, P.T, October 2013. Poster Presentation 2013
  • Demographic Differences Between Cancer Patients with Veterans Health Administration (VHA) Insurance and Those with Medicaid, Medicare, Private or No Insurance, AVAHO (Association of VA Hematology/Oncology) Sanders, S, Bha, VR, Silberstein, P.T, October 2013. Poster Presentation 2013
  • Distribution of Stage IV Cervical Cancer Among Patients with Different Insurance., AVAHO (Association of VA Hematology/Oncology) Olsen D, Silberstein P.T, October 2013. Poster Presentation 2013
  • "The Role of Tarceva (erlotinib) in the Treatment of Locally Advanced or Metastatic NSCLC after Chemotherapy Failure", 2005
  • "Advances in the Treatment of Metastastic Colorectal Cancer", Des Moines, IA 2005
  • "First-Line Therapy for Non Small Cell Lung Cancer", Central IA Oncology Nursing Society, Des Moines, IA 2005
  • "The Changing Face of Chemotherapy for Colorectal Cancer" - The 13th Annual Management of Colon and Rectal Disease, Qwest Center, Omaha, NE 2005
  • "The Role of Tarceva (erlotinib) in the Treatment of Locally Advanced or Metastatic NSCLC after Chemotherapy Failure", University of New Mexico, Albuquerque, NM 2005
  • "New Therapies for Lung Cancer", Kansas City, MO 2005
  • "Transdermal Gels to Treat Chemotherapy Induced Nausea and Vomiting", Oncology Section Research Conference, Lied Transplant Center, UNMC, Omaha, NE. 2005
  • "Advances in the Treatment of Early Stage Breast Cancer", Winner, S.D. 2005
  • "Advancing the CINV Treatment Paradigm", French Cafe, Omaha, NE 2005
  • "Advancing the CINV Treatment Paradigm", Des Moines, IA 2005
  • "Advancing the CINV Treatment Paradigm", Kearney, NE 2005
  • "Advancing the CINV Treatment Paradigm", Indianapolis, IN 2004
  • Silberstein, P.T., Jones, D.H., Ternent, C., Lynch, H.T., Regression of Colorectal Cancer Adenomas with Intravenous Chemotherapy in a Patient with Familial Adenomatous Polyposis., American Society of Clinical Oncology Annual Meeting - Poster Presentation - Supplement Abstract No: 1021 2004
  • "Eributex" - Sioux Falls, S.D. 2004
  • Myleoproliferative Disorders Grand Rounds 2004
  • Myleoproliferative Disorders Grand Rounds 2004
  • Erbitux Treatment of Metastatic Colorectal Cancer Omaha, NE 2004
  • Update on Cancer Pain Lincoln, NE 2004
  • New Advances in the Treatment of First Line Non-Small Cell Lung Cancer Spokane, WA (third different site for this area) 2004
  • New Advances in the Treatment of First Line Non-Small Cell Lung Cancer Coeur d'Alene, ID 2004
  • New Advances in the Treatment of First Line Non-Small Cell Lung Cancer Spokane, WA 2004
  • New Advances in the Treatment of First Line Non-Small Cell Lung Cancer Spokane, WA (additional site presentation) 2004
  • Advances in Chemotherapy for Colorectal Cancer Omaha, NE 2004
  • Update in Breast Cancer Aberdeen, SD 2004
  • Update in Breast Cancer Pierre, SD 2004
  • Moderator of American Society of Hematology Review 2003 Marriot, Omaha NE 2004
  • Controversies of Prevention and Early Detection of Breast Cancer Grand Rounds 2003
  • Advances in the Treatment of Metastatic Breast Cancer North Platte, NE 2003
  • Advances in the Treatment of Metastatic Breast Cancer Robinsdale, MN 2003
  • "Advances in the Treatment of Metastatic Breast Cancer" - Waconia, MN 2003
  • "Update in Treatment of Cancer Pain" - Grand Rounds - Creighton University Medical Center 2003
  • "Bloodless Medicine and the Cancer Center" - Bloodless Medicine and Surgery Program Seminar 2003
  • "Advances in the Treatment of Metastatic Breast Cancer" - Rapid City, SD 2003
  • "Management of Cancer Pain" & "Treatment of Pain in Cancer" - 4th Annual Pain Management Conference: Mechanisms and Methods for Managing Pain - Omaha, NE 2003
  • "New Advances in the Treatment of 1st Line NSCLC" - Oral Presentation - Minneapolis, MN 2003
  • "Chemotherapy Induced Nausea and Vomiting" - Oral Presentation - Omaha, NE 2003
  • "New Advances in the Treatment of 2nd Lne NSCLC" - Oral Presentation - Council Bluffs, IA 2002
  • "New Advances in the Treatment of 2nd Line NSCLC" - Oral Presentation - Shakopee, MN 2002
  • "New Advances in the Treatment of 2nd Line NSCLC" - Oral Presentation - Burnsville, MN 2002
  • "Hormone Therapy for Breast Cancer" - Grand Rounds, Morrison Seminar Room, Creighton Universtiy Medical Center 2002